PFBT
IPXL

Parkside Financial Bank & Trust’s Impax Laboratories, Inc. IPXL Stock Holding History

Parkside Financial Bank & Trust’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-70
Closed -$1K – 1666
2018
Q1 		$1K Buy
70
+23
+49% +$451 ﹤0.01% 1417
2017
Q4 		$1K Hold
47
– – ﹤0.01% 1326
2017
Q3 		$1K Hold
47
– – ﹤0.01% 1332
2017
Q2 		$1K Buy
+47
New +$694 ﹤0.01% 1358
2017
Q1 		– Sell
-51
Closed -$1K – 1610
2016
Q4 		$1K Buy
+51
New +$872 ﹤0.01% 1319

Parkside Financial Bank & Trust's IPXL Position: Q2 2018 in Review

Parkside Financial Bank & Trust sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 70 shares — an estimated $1K sold.

Parkside Financial Bank & Trust first reported a position in IPXL in Q4 2016 and held it in 5 quarters. The position peaked at $1K in Q1 2018. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

  • Parkside Financial Bank & Trust reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 70 Impax Laboratories, Inc. shares in Q2 2018, an estimated $1K.
  • Parkside Financial Bank & Trust first reported a position in Impax Laboratories, Inc. in Q4 2016 and held it in 5 quarters.
  • Parkside Financial Bank & Trust's Impax Laboratories, Inc. position peaked at $1K in Q1 2018.
  • 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2018, filed 3 Aug 2018.